Skip to main content
. 2021 Dec 14;11:773063. doi: 10.3389/fonc.2021.773063

Figure 1.

Figure 1

The role of CD248 in RCC progression. (A, B) CD248 overexpression in RCC. (C) Kaplan–Meier analysis of the OS in high and low CD248-expressing patients with RCC in the TCGA cohort. (D) Clinicopathological correlation of CD248 in RCC. (E) GSEA of KEGG pathways analysis. (F) Heatmap of TME cells was shown after grouping by CD248. p < 0.05 was considered statistically significant.